Corrected: Bipartisan IRA fix seeks to align small molecule and biologic negotiation periods
As the biopharma industry has loudly criticized a provision in the Inflation Reduction Act that provides for negotiations to happen sooner for small molecule drugs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.